Stay updated on ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.

Latest updates to the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page’s displayed revision/version label was updated from `v3.5.2` to `v3.5.3`, indicating a minor site update without changing the study record details.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.2 is now displayed on the site. The funding-lapse notice and the v3.4.1 revision entry have been removed.SummaryDifference0.4%

- Check86 days agoChange DetectedA system notice about a lapse in government funding and current operating status was added, and the page revision was updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.